Curis Investor Relations Material
Latest events
Q1 2025
Curis
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Curis Inc
Access all reports
Curis Inc. is a biotechnology company focused on developing innovative therapies for the treatment of cancer. The company's research and development efforts concentrate on targeting signaling pathways that play a key role in the growth and survival of cancer cells. Curis works on both proprietary drug candidates and in collaboration with strategic partners to advance its oncology-focused pipeline. Its therapeutic approach includes small molecules and immunotherapies aimed at addressing various forms of cancer, with the goal of improving patient outcomes. The company is headquartered in Lexington, Massachusetts, and its shares are listed on the NASDAQ.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
CRIS
Country
🇺🇸 United States